ACNB Corporation Reports 2024 Third Quarter Financial Results
GETTYSBURG, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) — ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $7.2 million, or...
53% of U.S. Tenants Face Housing Affordability Crisis
FORT COLLINS, Colo., Oct. 24, 2024 (GLOBE NEWSWIRE) — A recent study from all-in-one landlord software TurboTenant reveals that over half of renters spend more than 30% of their gross income on rent, meaning...
NAPC Defense (OTCPK: BLIS) Awarded in Excess of $1 Million in Clean-up Contracts following Hurricanes Helene and Milton
LARGO, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) — NAPC Defense, Inc., (OTCPK: BLIS) (“NAPC” or “the Company”) announced today that the Company has received in excess of $1 million in new orders for support...
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
Metagenomi Adenine Base Editors (ABEs) demonstrated over 95% genome targetability Simultaneous ABE triplex editing resulted in over 95% protein knockdown in primary T-cells ABE demonstrated highly specific on-target deamination with no detectable translocations and...
First Merchants Corporation Announces Third Quarter 2024 Earnings per Share
MUNCIE, Ind., Oct. 24, 2024 (GLOBE NEWSWIRE) — First Merchants Corporation (NASDAQ – FRME) Third Quarter 2024 Highlights: Net income available to common stockholders was $48.7 million and diluted earnings per common share totaled...
Outbrain to Release Third Quarter 2024 Financial Results on November 7, 2024
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Outbrain Inc. (NASDAQ: OB) announced today that the company will release its third quarter 2024 results before the market opens on Thursday, November 7, 2024, followed...
Carpenter Technology Reports First Quarter Fiscal Year 2025 Results
Delivered Record First Quarter Operating IncomeExceeded First Quarter Operating Income Guidance for Specialty Alloys Operations SegmentExpanded Operating Margins in Specialty Alloys Operations SegmentGenerated Positive Adjusted Free Cash FlowRepurchased Shares Against Authorized Share Repurchase ProgramStrengthening...
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address...
Dupixent® (dupilumab) Late-Breaking Positive Phase 3 Data in Chronic Spontaneous Urticaria to Be Presented at ACAAI
Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease status Confirmatory data to support U.S. regulatory resubmission by year-end; if approved, Dupixent would be the first new targeted...
First Watch Restaurant Group, Inc. to Report Third Quarter 2024 Financial Results on November 7, 2024
BRADENTON, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it...
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress
Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies On track to initiate IND-enabling activities for Wilson’s...
Paycor Welcomes Industry Leader Dru Armstrong, CEO of AffiniPay, to Board of Directors
CINCINNATI, Oct. 24, 2024 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management (HCM) software, today announced the election of Dru Armstrong to its Board of Directors, effective October...
Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer
Seasoned Biotech Executive Further Strengthens Company’s Leadership Team Sandy Loreaux, former CEO, to Remain on Board of Directors LEBANON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) — Bryn Pharma, LLC, a privately held pharmaceutical company...
Nasdaq Giants and Rising Innovators Face Critical Earnings Reports This Quarter
PALM BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) — FN Media Group Market Commentary – Investors Brace for a High-Stakes Earnings Season as Key Players in Tech, EVs, and AI Reveal Their Performance. As...
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
Bayer obtains global license to develop and commercialize disease-modifying treatment specifically for dilated cardiomyopathy (DCM) patients characterized by specific mutations Post-licensing, companies will continue to collaborate on cardiovascular and renal programs Dewpoint will receive...
GoHealth to Announce Third Quarter 2024 Results on November 7, 2024
CHICAGO, Oct. 24, 2024 (GLOBE NEWSWIRE) — GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2024 financial results on the...
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
STOUGHTON, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it...
Esperion to Report Third Quarter 2024 Financial Results on November 7
ANN ARBOR, Mich., Oct. 24, 2024 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced it will report third quarter 2024 financial results before the market opens on Thursday, November 7, 2024. Following the release,...
Columbia Financial, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2024
FAIR LAWN, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) — Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank (“Columbia”), reported net income of $6.2 million, or $0.06 per basic...
FTI Consulting Reports Third Quarter 2024 Financial Results
WASHINGTON, Oct. 24, 2024 (GLOBE NEWSWIRE) — Third Quarter 2024 Revenues of $926.0 Million, Up 4% Compared to $893.3 Million in Prior Year Quarter Third Quarter 2024 EPS of $1.85, Down 21% Compared to...
Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Annual Conference
CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer’s Disease (CTAD) annual conference, taking place October 29 – November...
Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium
– Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small cell lung cancer (NSCLC) – First safety data presented from combination study of PRT3789 and...
Protein Hydrolysates Market Size on Track for USD 6.6 Billion by 2031, Expanding at 6.1% CAGR as Demand for High-Purity Proteins for Muscle Recovery Soars| Transparency Market Research Inc.
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Oct. 24, 2024 (GLOBE NEWSWIRE) — The global protein hydrolysates industry was worth US$ 3.8 billion in 2022. Between 2023 and 2031, it is expected...
TeraWulf Inc. Announces Upsize and Pricing of $425 Million Convertible Notes Offering
EASTON, Md., Oct. 24, 2024 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, next-generation digital infrastructure powered by predominantly zero-carbon energy, today announced...
Soft Tissue Repair Market Size to Worth USD 12.78 Billion by 2034 With 5.6% CAGR | Fact.MR Report
Rockville, MD, Oct. 24, 2024 (GLOBE NEWSWIRE) — According to a new industry report released by Fact.MR, the global soft tissue repair market size is expected to reach a size of US$ 7.39 billion in 2024 and further...
Kelly Announces Third-Quarter 2024 Conference Call
TROY, Mich., Oct. 24, 2024 (GLOBE NEWSWIRE) — Kelly, a leading global specialty talent solutions provider, will release its third-quarter earnings before the market opens on Thursday, November 7, 2024. In conjunction with its...
PeopleOne Health Secures up to $32.3 Million Series B Funding Led by GV (Google Ventures) to Expand Access to Affordable, High-Quality Primary Care
PITTSBURGH, Oct. 24, 2024 (GLOBE NEWSWIRE) — PeopleOne Health, a pioneer in value-based primary care, today announced the close of up to $32.3 million Series B funding, led by GV (Google Ventures), with participation...
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) — Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...
Global Key Opinion Leader Management Market Set to Grow at 12.5% CAGR, Surpassing USD 211.27 Billion by 2032 Amid Increasing Demand | FMI
NEWARK, Del, Oct. 24, 2024 (GLOBE NEWSWIRE) — The Key Opinion Leader (KOL) Management Market has seen significant growth in recent years, driven by the rising importance of KOLs in sectors such as pharmaceuticals,...
BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024
– Continued, progressive improvement in motor function and achievement of motor milestones at 12-months post-treatment represents an important and statistically significant change, in contrast to the disease course observed in BridgeBio’s ongoing CANinform natural...
ZenaTech’s AI Drone Company Acquires Drone Design Patent From Former Parent Company
TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS (Software-as-a-Service) solutions, today announces that its subsidiary, ZenaDrone, is...
Frozen Food Market is Expected To Reach USD 510.06 Billion by 2032, Growing at CAGR of 5.9 % | Introspective Market Research
Russia, Moscow, Oct. 24, 2024 (GLOBE NEWSWIRE) — Frozen food Market refers to food products that are preserved through freezing to maintain their freshness, texture, and nutritional value over extended periods. This method involves...
The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results
SCOTTSDALE, Ariz., Oct. 24, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT) the nation’s largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2024 financial results on Thursday,...
Valley National Bancorp Announces Third Quarter 2024 Results
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the third quarter 2024 of $97.9 million, or $0.18 per...
Virtu Announces Third Quarter 2024 Results
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative, transparent trading solutions to its...
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
WILMETTE, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced that it has entered...
Flock Safety Launches First-of-Its-Kind Sideshow Detection Technology to Help Communities Combat Illegal Sideshows
Atlanta, GA, Oct. 24, 2024 (GLOBE NEWSWIRE) — Flock Safety, the leading public safety technology company, today announced the launch of their first-of-its-kind sideshow detection technology. The artificial intelligence (AI) and machine learning (ML)-powered...
Pool Corporation Reports Third Quarter Results
Highlights Resilient recurring maintenance revenues contributed to Q3 2024 net sales of $1.4 billion Seasonal gross margin of 29.1% Operating income of $176.4 million and operating margin of 12.3% Q3 2024 diluted EPS of...
ConnectOne Bancorp, Inc. Reports Third Quarter 2024 Results; Declares Common and Preferred Dividends
ENGLEWOOD CLIFFS, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of...
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will...
Auron Presents New Preclinical Data for Lead Program AUTX-703 Across Multiple Cancer Types
Treatment with AUTX-703 resulted in notable cell differentiation and tumor growth inhibition in various primary cancer models AUTX-703 IND submission on track for late 2024 NEWTON, Mass. , Oct. 24, 2024 (GLOBE NEWSWIRE) —...
Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference
– Posters to highlight the safety data, tolerability data, and antitumor efficacy data of VP-315 for the treatment of basal cell carcinoma as determined by histological clearance – WEST CHESTER, Pa., Oct. 24, 2024...
VSDHOne Expands to Offer Asynchronous Telehealth Treatments Including Skincare, Hair Loss, and Sexual Health
VANCOUVER, British Columbia and LAS VEGAS, Oct. 24, 2024 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing mobile clinical network and medical platform,...
Nasdaq Reports Third Quarter 2024 Results; Fourth Consecutive Quarter of Double-Digit Solutions Revenue Growth
NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2024. Third quarter 2024 net revenue1 was $1.1 billion, or $1.2 billion on...
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens
Key Highlights: Projecting $3.8M in Q1 revenue, with strong growth throughout the year Inflecting to Positive Cash Flow Beginning in Q1 2025 Peru Facility Now Operational, Producing Initial Orders and Capturing High Margins Nation’s...
DTE Energy reports third quarter 2024 accomplishments, earnings and investments in improving energy infrastructure
Continued on path to improving electric reliability through investments in smart grid technology and new substations Began construction of three new solar parks, all funded by company’s voluntary MIGreenPower program Installed nearly 1,000 free...
The Simply Good Foods Company Reports Fiscal Fourth Quarter and Full Fiscal Year 2024 Financial Results and Provides Full Fiscal Year 2025 Outlook
DENVER, Oct. 24, 2024 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported...
Steering Shaft Market Projected to Grow at 3.3% CAGR, Reaching $7.9 Billion by 2033 | Fact.MR report
Rockville, MD, Oct. 24, 2024 (GLOBE NEWSWIRE) — According to Fact.MR, a market research and competitive intelligence provider, the global steering shaft market is estimated to be valued at US$ 5.7 Billion in 2023 and is expected to...
Kymera Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader, for the Treatment of TH2 Immuno-Inflammatory Diseases
KT-621, an oral degrader, is the first STAT6 targeted medicine to enter clinical development, with the potential to address multiple immuno-inflammatory diseases KT-621 has demonstrated dupilumab-like activity and was well tolerated in a wide...
Ultralife Corporation to Report Third Quarter Results on November 8, 2024
NEWARK, N.Y., Oct. 24, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2024 before the market opens on Friday, November 8, 2024....
2024 Fortune Best Workplaces for Women Lead the Way Beyond Fair Pay
Oakland, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — The 2024 Fortune Best Workplaces for Women™ are setting standards for gender equity in the workplace by going beyond fair pay and promotions to create environments...